Clinical Safety

FDA Warns of Dangerous Online Cancer Scams
Research & Development FDA Warns of Dangerous Online Cancer Scams

In the face of a life-altering diagnosis, the search for hope can lead patients and their families down countless digital rabbit holes, where unscrupulous vendors lie in wait with promises of miraculous cures sold through slick websites and persuasive social media campaigns. The U.S. Food and Drug

Targeted mRNA Therapy Restores Fertility in Mice
Research & Development Targeted mRNA Therapy Restores Fertility in Mice

In a landmark development for reproductive medicine, a novel messenger RNA (mRNA) treatment has successfully repaired uterine damage and restored fertility in mice, offering a potential new path forward for treating certain forms of human infertility. The study, detailed in Nature Nanotechnology ,

What Is the Immune System’s Achilles’ Heel?
Research & Development What Is the Immune System’s Achilles’ Heel?

A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue

Large Study Finds No Stomach Cancer Risk From PPIs
Research & Development Large Study Finds No Stomach Cancer Risk From PPIs

For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among

Scientists Make the Case for Essential Fiber
Research & Development Scientists Make the Case for Essential Fiber

For the first time in over half a century, the fundamental list of nutrients considered indispensable for human life may be on the verge of a historic update, with the candidate being a familiar yet profoundly misunderstood dietary component. A concerted effort by leading nutrition experts is

Dual-Action Therapy Prevents Liver Cancer Recurrence
Research & Development Dual-Action Therapy Prevents Liver Cancer Recurrence

A groundbreaking therapeutic strategy that combines a systemic targeted drug with a standard locoregional treatment is showing unprecedented promise in preventing the recurrence of hepatocellular carcinoma (HCC) among high-risk patients who have undergone surgery. This comprehensive analysis of a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later